MATINAS BIOPHARMA HOLDINGS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $85.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $85.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $112.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $332.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $389.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-03-31 | $85.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $112.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $332.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $389.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $451.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $516.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $586.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $659.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $736.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $816.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $987.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.17M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $1.27M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.16M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.25M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $1.34M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.07M 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $1.22M 10-K/A · filed 2022-03-11 | |
| 2020-03-31 | $1.47K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.55K 10-Q · filed 2020-05-11 | $1.55M 10-K · filed 2020-03-09 |
| 2019-09-30 | $1.64M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.73K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |